GE HealthCare touts new opportunities for diagnosing, monitoring Alzheimer’s disease


GE HealthCare Technologies executives surprised investment analysts July 25 with the news that the company’s imaging product business, which has a major presence in metro Milwaukee, is likely to see increased sales related to products necessary for new Alzheimer’s treatment regimes.

Previous Centene CEO Sarah London executes new strategy, seeks to 'balance' civic investments
Next Frescobaldi move into Oregon wine shows state's continuing lure for big European players